CUBIST SYSTEMATIC STRATEGIES, LLC – Alnylam Pharmaceuticals, Inc. Transaction History
CUBIST SYSTEMATIC STRATEGIES, LLC portfolio value:
$20.57M
portfolio value
CUBIST SYSTEMATIC STRATEGIES, LLC quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +1555.35% | 96.60K shares | 19.67M | $200.16 | 102.81K |
Q2 2022 | share | Decrease | -77.98% | -21.98K shares | -3.69M | $145.85 | 6.21K |
Q1 2022 | share | Increase | +59.63% | 10.53K shares | 1.60M | $163.29 | 28.2K |
Q4 2021 | share | Increase | +4.61% | 778 shares | -193K | $171.03 | 17.66K |
Q3 2021 | share | Decrease | -24.50% | -5.48K shares | -603K | $188.81 | 16.88K |
Q2 2021 | share | Increase | +2028.35% | 21.31K shares | 3.64M | $169.52 | 22.36K |
Q1 2021 | share | Decrease | -95.48% | -22.19K shares | -2.87M | $141.19 | 1.05K |
Q4 2020 | share | Increase | +83.17% | 10.55K shares | 1.17M | $129.97 | 23.24K |
Q3 2020 | share | Decrease | -31.12% | -5.73K shares | -880K | $145.6 | 12.68K |
Q2 2020 | share | Increase | 0.00% | 18.42K shares | 2.72M | $148.11 | 18.42K |
Q1 2020 | share | Decrease | -100.00% | -65.71K shares | -7.56M | $108.85 | 0 |
Q4 2019 | share | Increase | +8744.28% | 64.97K shares | 7.50M | $115.17 | 65.71K |
Q3 2019 | share | Decrease | -97.34% | -27.15K shares | -1.96M | $80.42 | 743 |
Q2 2019 | share | Increase | 0.00% | 27.89K shares | 2.02M | $72.56 | 27.89K |
Q1 2019 | share | Decrease | -100.00% | -30.17K shares | -2.2M | $93.45 | 0 |
Q4 2018 | share | Increase | +203.27% | 20.22K shares | 1.32M | $72.91 | 30.17K |
Q3 2018 | share | Increase | +5109.95% | 9.76K shares | 852K | $87.52 | 9.95K |
Q2 2018 | share | Decrease | -93.47% | -2.73K shares | -329K | $98.49 | 191 |
Q1 2018 | share | Decrease | -84.28% | -15.68K shares | -2.01M | $119.1 | 2.92K |
Q4 2017 | share | Increase | +2249.75% | 17.81K shares | 2.27M | $127.05 | 18.61K |
Q3 2017 | share | Decrease | -70.64% | -1.90K shares | -122K | $117.49 | 792 |
Q2 2017 | share | Decrease | -70.34% | -6.39K shares | -251K | $79.76 | 2.69K |
Q1 2017 | share | Increase | +19.08% | 1.45K shares | 180K | $51.25 | 9.09K |
Q4 2016 | share | Decrease | -35.64% | -4.23K shares | -518K | $37.44 | 7.63K |
Q3 2016 | share | Increase | +239.86% | 8.37K shares | 610K | $67.78 | 11.86K |
Q2 2016 | share | Decrease | -71.27% | -8.66K shares | -569K | $55.49 | 3.49K |
Q1 2016 | share | Increase | +175.81% | 7.74K shares | 348K | $62.77 | 12.15K |